loading page

AstraZeneca COVID-19 vaccine: A possible risk factor for Stroke, Case Series from Sudan
  • +5
  • Amira Siddig Omer,
  • Abbasher Hussien Mohamed Ahmed,
  • Khabab Mohamed Ahmed,
  • Abdallah M. Abdallah,
  • Mohamed Malekaldar,
  • AlHussien Abbasher,
  • Mohammed Abbasher,
  • Abubaker Alsedig Abbasher
Amira Siddig Omer
Al-Neelain University Faculty of Medicine
Author Profile
Abbasher Hussien Mohamed Ahmed
University of Khartoum Faculty of Medicine
Author Profile
Khabab Mohamed Ahmed
University of Khartoum Faculty of Medicine
Author Profile
Abdallah M. Abdallah
University of Bahri, Faculty of medicine
Author Profile
Mohamed Malekaldar
Omdurman Teaching Hospital
Author Profile
AlHussien Abbasher
AlYarmouk college
Author Profile
Mohammed Abbasher
Al-Neelain University Faculty of Medicine
Author Profile
Abubaker Alsedig Abbasher
Zamzam University college
Author Profile

Abstract

Cerebrovascular accident (CVA) is one of the commonest neurological deficits. There is a well-known association between COVID-19 and stroke. We present a case series of Sudanese patients who developed CVA after receiving the AstraZeneca COVID-19 vaccine suggesting a relationship between the vaccine and CVA.

Peer review status:UNDER REVIEW

18 Nov 2021Submitted to Clinical Case Reports
20 Nov 2021Assigned to Editor
20 Nov 2021Submission Checks Completed
25 Nov 2021Reviewer(s) Assigned